#UK #Haverhill #Codis #Steven Facer

Codis Welcomes Steven Facer as Senior VP of Sales and Marketing for Haverhill Operations

In a significant move to bolster its leadership team, Codis has appointed Steven Facer as Senior Vice President of Sales and Marketing for its Haverhill facility in the UK. With over 30 years of extensive experience in the pharmaceutical sector, Facer's appointment is expected to drive commercial growth and enhance strategic partnerships for the company.

Facer brings a wealth of expertise from his impressive career spanning leadership roles at esteemed organizations such as Thermo Fisher Scientific, Capsugel, and Catalent Pharma Solutions. His proven track record includes launching successful sales and marketing strategies, and expanding international market presence, indicating his capability to lead Codis’s commercial ventures in the rapidly evolving pharmaceutical landscape.

The choice of Facer was influenced heavily by his previous accomplishments, particularly during his role as Senior Vice President of Global Sales and Marketing at Adare Pharma Solutions. His leadership there resulted in substantial market expansion and commercial success. Prior to joining Adare, Facer held various positions in business development and operations, where he gained significant insights into value pricing, contract negotiations, and lean manufacturing principles.

Codis CEO Nicolas Fortin expressed confidence in Facer’s abilities, stating, “Steve's extensive experience and strong leadership make him the ideal choice to lead our Haverhill sales and marketing strategy. His commercial acumen and ability to build customer-focused partnerships will be invaluable as we continue to expand our services.” This highlights the importance of Facer's role in furthering Codis's mission to be a trusted partner in the pharmaceutical field.

In his new position at Codis, Facer will spearhead the company's sales and marketing strategy in Haverhill, focusing on deepening customer relationships and accelerating growth in pharmaceutical solutions. His vision aligns with Codis's overarching commitment to quality and innovation in its offerings.

Expressing his enthusiasm for the role, Facer remarked, “I am excited to join Codis at such a pivotal time. Codis's commitment to quality, innovation, and customer success aligns perfectly with my passion for advancing pharmaceutical solutions that make a real difference to patients worldwide.” This statement reinforces his dedication to not only expand Codis's market presence but also to provide impactful solutions to the pharmaceutical industry.

Codis itself is a globally recognized Contract Development and Manufacturing Organization (CDMO) specializing in areas such as commercial spray drying, amorphous solid dispersions, and particle engineering technologies. The company operates with cGMP facilities in St. Louis, Missouri; Seymour, Indiana; and Haverhill, UK, ensuring comprehensive regulatory compliance and manufacturing strength. With a mission of driving innovation in the pharmaceutical, consumer health, nutraceutical, and OTC sectors, Codis is well-positioned for sustainable growth under Facer's leadership.

With Facer's appointment to lead the sales and marketing efforts at the Haverhill facility, Codis aims to reinforce its industry stance and capitalize on its extensive capabilities to meet the ever-changing demands of the pharmaceutical market. This strategic move sets the stage for potential advancements in how the company approaches growth, partnerships, and client satisfaction moving forward.

The future looks bright for Codis as it embarks on this new chapter under Steven Facer's capable guidance. The pharmaceutical landscape is evolving rapidly, and Codis is ready to adapt and thrive, ensuring it remains a key player in delivering high-quality pharmaceutical solutions to its customers around the globe.